27.06.2013 Views

Proceedings of the 12th European Conference on Knowledge ...

Proceedings of the 12th European Conference on Knowledge ...

Proceedings of the 12th European Conference on Knowledge ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

4. What a bi<str<strong>on</strong>g>of</str<strong>on</strong>g>eedback is<br />

Manel G<strong>on</strong>zález-Piñero et al<br />

Bi<str<strong>on</strong>g>of</str<strong>on</strong>g>eedback, is in simple terms, a means <str<strong>on</strong>g>of</str<strong>on</strong>g> attaching a device whe<str<strong>on</strong>g>the</str<strong>on</strong>g>r it have sound, lights or a<br />

picture, to show <str<strong>on</strong>g>the</str<strong>on</strong>g> patient how <str<strong>on</strong>g>the</str<strong>on</strong>g>y are performing. It can be as simple as touching a muscle with<br />

<strong>on</strong>es fingers to feel when it c<strong>on</strong>tracts. It has been defined as: '… <str<strong>on</strong>g>the</str<strong>on</strong>g> detecti<strong>on</strong> <str<strong>on</strong>g>of</str<strong>on</strong>g> a physiological<br />

process (ei<str<strong>on</strong>g>the</str<strong>on</strong>g>r directly or indirectly) and <str<strong>on</strong>g>the</str<strong>on</strong>g> presentati<strong>on</strong> <str<strong>on</strong>g>of</str<strong>on</strong>g> this informati<strong>on</strong> to a patient who is <str<strong>on</strong>g>the</str<strong>on</strong>g>n<br />

able, with training, to use <str<strong>on</strong>g>the</str<strong>on</strong>g> informati<strong>on</strong> to gain c<strong>on</strong>trol over <str<strong>on</strong>g>the</str<strong>on</strong>g> process.'<br />

It is a technique developed over <str<strong>on</strong>g>the</str<strong>on</strong>g> last 3 decades, which is intended to teach subjects to bring<br />

certain physiologic processes under voluntary c<strong>on</strong>trol. Applicati<strong>on</strong> <str<strong>on</strong>g>of</str<strong>on</strong>g> this technique to medical<br />

c<strong>on</strong>diti<strong>on</strong>s was popularized during <str<strong>on</strong>g>the</str<strong>on</strong>g> 1970s, al<strong>on</strong>g with a variety <str<strong>on</strong>g>of</str<strong>on</strong>g> o<str<strong>on</strong>g>the</str<strong>on</strong>g>r behavioural <str<strong>on</strong>g>the</str<strong>on</strong>g>rapies<br />

(Subcommittee <strong>on</strong> N<strong>on</strong>pharmacologic Therapy Report, 1986). These <str<strong>on</strong>g>the</str<strong>on</strong>g>rapies were primarily directed<br />

toward disorders that were thought to include a comp<strong>on</strong>ent <str<strong>on</strong>g>of</str<strong>on</strong>g> stress, psychosomatic, or<br />

psychophysiologic features.<br />

5. Benefits <str<strong>on</strong>g>of</str<strong>on</strong>g> bi<str<strong>on</strong>g>of</str<strong>on</strong>g>eedback vs. medicati<strong>on</strong><br />

There are multiple behavioural techniques and protocols, but <str<strong>on</strong>g>the</str<strong>on</strong>g>ir comparative efficacy is unknown.<br />

Because technical aspects cannot be detailed sufficiently in reports <str<strong>on</strong>g>of</str<strong>on</strong>g> clinical trials, behavioural<br />

interventi<strong>on</strong>s also are difficult to replicate in practice. One behavioural technique, bi<str<strong>on</strong>g>of</str<strong>on</strong>g>eedback, has<br />

been even less widely used for urge inc<strong>on</strong>tinence because it <str<strong>on</strong>g>of</str<strong>on</strong>g>ten has required repeated<br />

instrumentati<strong>on</strong> <str<strong>on</strong>g>of</str<strong>on</strong>g> <str<strong>on</strong>g>the</str<strong>on</strong>g> bladder and urinary sphincter (Resnick, 1998). Moreover, despite <str<strong>on</strong>g>the</str<strong>on</strong>g> expertise<br />

and time entailed, behavioural techniques are poorly reimbursed. By c<strong>on</strong>trast, pharmaco<str<strong>on</strong>g>the</str<strong>on</strong>g>rapy<br />

works more quickly and also requires no behavioural expertise, less physician time, and less patient<br />

participati<strong>on</strong>. N<strong>on</strong>e<str<strong>on</strong>g>the</str<strong>on</strong>g>less, although drugs help most patients, n<strong>on</strong> drug restores c<strong>on</strong>tinence to <str<strong>on</strong>g>the</str<strong>on</strong>g><br />

majority. Fur<str<strong>on</strong>g>the</str<strong>on</strong>g>rmore, all <str<strong>on</strong>g>of</str<strong>on</strong>g> <str<strong>on</strong>g>the</str<strong>on</strong>g> agents currently used engender adverse effects, expense, and<br />

inc<strong>on</strong>venience (Fantl et al., 1996), and most must be taken several times daily and indefinitely. Thus,<br />

an equally or more effective <strong>on</strong>e-time interventi<strong>on</strong> would be welcome.<br />

The study by Burgio (Burgio et al., 1998) dem<strong>on</strong>strates that a less-invasive bi<str<strong>on</strong>g>of</str<strong>on</strong>g>eedback approach can<br />

achieve <str<strong>on</strong>g>the</str<strong>on</strong>g>se goals. The study also serves as a rich source <str<strong>on</strong>g>of</str<strong>on</strong>g> informati<strong>on</strong> and provides valuable<br />

less<strong>on</strong>s for clinicians. The investigators’ decisi<strong>on</strong> to begin <str<strong>on</strong>g>the</str<strong>on</strong>g>rapy with oxybutynin at 2.5mg3 times<br />

daily was wise. The effect <str<strong>on</strong>g>of</str<strong>on</strong>g> oxybutynin was equivalent to that achieved in trials using higher<br />

dosages, but it caused far fewer adverse effects and a lower rate <str<strong>on</strong>g>of</str<strong>on</strong>g> subject attriti<strong>on</strong> (Fantl et al.<br />

1996). Equally important, efficacy c<strong>on</strong>tinued to increase bey<strong>on</strong>d 2 weeks, l<strong>on</strong>ger than previously<br />

reported, but c<strong>on</strong>sistent with o<str<strong>on</strong>g>the</str<strong>on</strong>g>r recent data (Appell, 1997) (Abrams et al., 1998). Thus, clinicians<br />

should avoid escalating dosages <str<strong>on</strong>g>of</str<strong>on</strong>g> oxybutynin too quickly or aband<strong>on</strong>ing pharmaco<str<strong>on</strong>g>the</str<strong>on</strong>g>rapy too so<strong>on</strong>.<br />

6. The open innovati<strong>on</strong> process followed in <str<strong>on</strong>g>the</str<strong>on</strong>g> R&D process <str<strong>on</strong>g>of</str<strong>on</strong>g> a<br />

Bi<str<strong>on</strong>g>of</str<strong>on</strong>g>eedback for urinary inc<strong>on</strong>tinence<br />

Technology<br />

Detecti<strong>on</strong><br />

Selecti<strong>on</strong> Evaluati<strong>on</strong> Protecti<strong>on</strong> Exploitati<strong>on</strong><br />

License<br />

Transfer<br />

Spin‐<str<strong>on</strong>g>of</str<strong>on</strong>g>f<br />

Agreement<br />

Figure 4: Technical University <str<strong>on</strong>g>of</str<strong>on</strong>g> Catal<strong>on</strong>ia’s Value Chain<br />

“Open innovati<strong>on</strong> is a paradigm that assumes that firms can and should use external ideas as well as<br />

internal ideas, and internal and external paths to market, as <str<strong>on</strong>g>the</str<strong>on</strong>g> firms look to advance <str<strong>on</strong>g>the</str<strong>on</strong>g>ir<br />

technology” , as Chesbrough (2003: Introducti<strong>on</strong>), defined in his work. The boundaries between a firm<br />

and its envir<strong>on</strong>ment have become more permeable; innovati<strong>on</strong>s can easily transfer inward and<br />

outward. The central idea behind open innovati<strong>on</strong> is that in a world <str<strong>on</strong>g>of</str<strong>on</strong>g> widely distributed knowledge,<br />

companies cannot afford to rely entirely <strong>on</strong> <str<strong>on</strong>g>the</str<strong>on</strong>g>ir own research but should instead buy or license<br />

processes or inventi<strong>on</strong>s (i.e. patents) from o<str<strong>on</strong>g>the</str<strong>on</strong>g>r companies.<br />

336

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!